Drugs / Allogeneic Mesenchymal Precursor Cells (MPCs)
Allogeneic Mesenchymal Precursor Cells (MPCs)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00555828 | Mar 2008 → Dec 2013 | myocardial infarction | Angioblast Systems | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic Mesenchymal Precursor Cells (MPCs) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00555828 ↗ |
| Modality | Cell therapy | “allogeneic mesenchymal precursor cells (MPCs)” NCT00555828 ↗ |
| Route | Other | “25 M allogeneic MPCs by transendocardial injection” NCT00555828 ↗ |